Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919122305Aexternal-prioritypatent/GB9122305D0/en
Priority claimed from GB929213538Aexternal-prioritypatent/GB9213538D0/en
Priority claimed from GB929220570Aexternal-prioritypatent/GB9220570D0/en
Application filed by Ici PlcfiledCriticalIci Plc
Publication of MX9205778ApublicationCriticalpatent/MX9205778A/en
La invención provee un compuesto novedoso, la 9-(3-cianofenil)-3,4,6,7,9,10-hexahidro-1,8-(2H,5H )-acridinadiona y sus sales de adición de ácido farmacéuticamente aceptables, las composiciones farmacéuticas que contienen el compuesto, y el uso del compuesto en el tratamiento de incontinencia urinaria.The invention provides a novel compound, 9- (3-cyanophenyl) -3,4,6,7,9,10-hexahydro-1,8- (2H, 5H) -acridinadione and its pharmaceutically acceptable acid addition salts , the pharmaceutical compositions containing the compound, and the use of the compound in the treatment of urinary incontinence.
USE OF 2'2'-DIFLUORONUCLEOSIDS FOR THE PREPARATION OF A PHARMACEUTICAL MEDICINAL PRODUCT AND COMPOSITION AND PHARMACEUTICAL PRODUCT CONTAINING THEM